Membrane‐Nanoparticle Interactions: The Impact of Membrane Lipids
Source abstract
Abstract
Abstract The growing field of nanotechnology presents opportunity for applications across many sectors. Nanostructures, such as nanoparticles, hold distinct properties based on their size, shape, and chemical modifications that allow them to be utilized in both highly specific as well as broad capacities. As the classification of nanoparticles becomes more well‐defined and the list of applications grows, it is imperative that their toxicity be investigated. One such cellular system that is of importance are cellular membranes (biomembranes). Membranes present one of the first points of contact for nanoparticles at the cellular level. This review will address current studies aimed at defining the biomolecular interactions of nanoparticles at the level of the cell membrane, with a specific focus of the interactions of nanoparticles with prominent lipid systems.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Lipid Membrane Structure and Behavior · Nanoparticle-Based Drug Delivery · Nanopore and Nanochannel Transport Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biological Sciences University of Calgary Calgary AB T2N 1N4 Canada
Funding
Natural Sciences and Engineering Research Council of Canada
References (100+)
Show source-provided references
1. 10.1039/C5NR07954C10.1039/C5NR07954C ↗
2. 10.1080/17458080.2017.141325310.1080/17458080.2017.1413253 ↗
3. 10.3389/fmicb.2023.115562210.3389/fmicb.2023.1155622 ↗
4. Mohanraj V. J. · Trop. J. Pharm. Res. · 2006 · 5 · 561
5. Turner R. J. · BioMetals · 2023 · 2023 · 545
6. 10.1021/cr400544s10.1021/cr400544s ↗
7. 10.1039/C8NR02278J10.1039/C8NR02278J ↗
8. Hasan S. · Res. J. Recent Sci. · 2015 · 4 · 2277
9. 10.1016/j.colsurfb.2014.03.01710.1016/j.colsurfb.2014.03.017 ↗
10. 10.1002/mco2.32710.1002/mco2.327 ↗
11. 10.1039/C1CS15188F10.1039/C1CS15188F ↗
12. 10.3390/nano1002026410.3390/nano10020264 ↗
13. 10.1007/s00204-013-1128-z10.1007/s00204-013-1128-z ↗
14. 10.1016/j.tibtech.2016.02.00610.1016/j.tibtech.2016.02.006 ↗
15. 10.1088/1757-899X/263/3/03201910.1088/1757-899X/263/3/032019 ↗
16. 10.1155/2012/93604110.1155/2012/936041 ↗
17. 10.1016/j.addr.2012.09.02110.1016/j.addr.2012.09.021 ↗
18. 10.1016/B978-0-443-21447-9.00001-110.1016/B978-0-443-21447-9.00001-1 ↗
19. 10.1186/s12951-022-01477-810.1186/s12951-022-01477-8 ↗
20. 10.1007/s12633-019-00229-y10.1007/s12633-019-00229-y ↗
21. 10.1002/smll.20190066910.1002/smll.201900669 ↗
22. Carvalho A. · 2018 · 257
23. 10.1146/annurev-food-041715-03321510.1146/annurev-food-041715-033215 ↗
24. 10.3390/vaccines1103065810.3390/vaccines11030658 ↗
25. 10.1021/acsnano.1c0499610.1021/acsnano.1c04996 ↗
26. 10.3233/JAD-19017010.3233/JAD-190170 ↗
27. 10.1021/acs.chemrev.7b0019410.1021/acs.chemrev.7b00194 ↗
28. 10.3390/molecules2516373110.3390/molecules25163731 ↗
29. 10.1016/S0168-3659(00)00339-410.1016/S0168-3659(00)00339-4 ↗
30. 10.2217/nnm-2019-044310.2217/nnm-2019-0443 ↗
31. 10.3390/nano1003049610.3390/nano10030496 ↗
32. 10.1016/j.jddst.2019.05.02610.1016/j.jddst.2019.05.026 ↗
33. 10.1021/acs.molpharmaceut.9b0105110.1021/acs.molpharmaceut.9b01051 ↗
34. 10.1177/11773928070020000210.1177/117739280700200002 ↗
35. 10.1016/S0939-6411(03)00139-510.1016/S0939-6411(03)00139-5 ↗
36. 10.3390/ijms2201038510.3390/ijms22010385 ↗
37. 10.1016/B978-0-12-814427-5.00015-910.1016/B978-0-12-814427-5.00015-9 ↗
38. R. J.Aitken K. S.Creely C. L.Tran Nanoparticles: An Occupational Hygiene Review 2009.
39. C.Ostiguy G.Lapointe L.Ménard Y.Cloutier M.Trottier M.Boutin M.Antoun C.Normand Nanoparticles – Actual Knowledge about Occupational Health and Safety Risks and Prevention Measures.
40. 10.1016/B978-0-12-814134-2.00001-210.1016/B978-0-12-814134-2.00001-2 ↗
41. 10.3390/polym1415311710.3390/polym14153117 ↗
42. 10.1155/2011/27097410.1155/2011/270974 ↗
43. Mann S. · 2011 · 17
44. 10.1017/S001675680001497710.1017/S0016756800014977 ↗
45. 10.1016/B978-0-08-102579-6.00012-510.1016/B978-0-08-102579-6.00012-5 ↗
46. 10.1016/B978-0-12-824272-8.00009-910.1016/B978-0-12-824272-8.00009-9 ↗
47. 10.1039/C4CS00362D10.1039/C4CS00362D ↗
48. 10.1039/C2CS35319A10.1039/C2CS35319A ↗
49. 10.1016/j.jclepro.2019.01.12210.1016/j.jclepro.2019.01.122 ↗
50. 10.1021/ja307589n10.1021/ja307589n ↗
51. 10.1002/adfm.20200540010.1002/adfm.202005400 ↗
52. 10.1021/ar600012y10.1021/ar600012y ↗
53. 10.1080/23746149.2016.125457010.1080/23746149.2016.1254570 ↗
54. Singh S. · 2019 · 395
55. 10.1007/s12560-014-9171-310.1007/s12560-014-9171-3 ↗
56. 10.1039/c2cs15327k10.1039/c2cs15327k ↗
57. 10.1016/j.colsurfb.2017.07.03810.1016/j.colsurfb.2017.07.038 ↗
58. 10.1007/s11051-012-1316-410.1007/s11051-012-1316-4 ↗
59. 10.3390/pharmaceutics1302019110.3390/pharmaceutics13020191 ↗
60. 10.1016/S0169-409X(02)00226-010.1016/S0169-409X(02)00226-0 ↗
61. 10.1007/s11095-010-0260-110.1007/s11095-010-0260-1 ↗
62. 10.1002/pi.305610.1002/pi.3056 ↗
63. 10.1016/j.reactfunctpolym.2021.10484910.1016/j.reactfunctpolym.2021.104849 ↗
64. 10.1016/j.watres.2014.05.05510.1016/j.watres.2014.05.055 ↗
65. 10.3390/molecules2811432810.3390/molecules28114328 ↗
66. 10.1016/j.ijpharm.2018.11.00110.1016/j.ijpharm.2018.11.001 ↗
67. 10.3109/10717544.2014.91676910.3109/10717544.2014.916769 ↗
68. 10.1039/C0CS00018C10.1039/C0CS00018C ↗
69. 10.1186/s40643-015-0076-210.1186/s40643-015-0076-2 ↗
70. 10.1016/j.jtemb.2016.11.01210.1016/j.jtemb.2016.11.012 ↗
71. 10.1016/j.apcata.2005.08.02910.1016/j.apcata.2005.08.029 ↗
72. 10.1016/j.micron.2013.10.00610.1016/j.micron.2013.10.006 ↗
73. 10.1016/j.nantod.2018.12.00610.1016/j.nantod.2018.12.006 ↗
74. 10.1016/j.colsurfb.2021.11225410.1016/j.colsurfb.2021.112254 ↗
75. 10.7150/thno.344810.7150/thno.3448 ↗
76. 10.2147/IJN.S21808510.2147/IJN.S218085 ↗
77. 10.1016/j.actbio.2007.11.00610.1016/j.actbio.2007.11.006 ↗
78. 10.1016/j.scitotenv.2006.11.00710.1016/j.scitotenv.2006.11.007 ↗
79. 10.1007/s12011-011-9266-810.1007/s12011-011-9266-8 ↗
80. 10.3390/ma704283310.3390/ma7042833 ↗
81. 10.1142/S0218625X1101444810.1142/S0218625X11014448 ↗
82. 10.3390/nano1002038710.3390/nano10020387 ↗
83. 10.2147/nano.2006.1.4.45110.2147/nano.2006.1.4.451 ↗
84. 10.1007/s13205-019-1626-710.1007/s13205-019-1626-7 ↗
85. 10.1016/j.cis.2015.01.00710.1016/j.cis.2015.01.007 ↗
86. 10.1111/j.1440-1681.2007.04733.x10.1111/j.1440-1681.2007.04733.x ↗
87. 10.1016/j.envres.2020.10981610.1016/j.envres.2020.109816 ↗
88. 10.1021/acs.est.9b0150510.1021/acs.est.9b01505 ↗
89. 10.1016/j.atmosenv.2023.11969810.1016/j.atmosenv.2023.119698 ↗
90. Premature deaths due to exposure to fine particulate matter in Europe https://www.eea.europa.eu/en/analysis/indicators/health‐impacts‐of‐exposure‐to(accessed: November 2024).
91. 10.1016/j.bbamem.2017.06.01610.1016/j.bbamem.2017.06.016 ↗
92. 10.1289/ehp.110467210.1289/ehp.1104672 ↗
93. Wildfire smoke air quality and your health: Overview – Canada.ca. https://www.canada.ca/en/services/health/healthy‐living/environment/air‐quality/wildfire‐smoke.html(accessed: December 2024).
94. Public health risk profile: Wildfires in Canada 2023 – Canada.ca. https://www.canada.ca/en/public‐health/services/emergency‐preparedness‐response/rapid‐risk‐assessments‐public‐health‐professionals/risk‐profile‐wildfires‐2023.html(accessed: December 2024).
95. Yang W. · Annu. Rev. · 2021 · 61 · 269
96. 10.1201/9780429399039-910.1201/9780429399039-9 ↗
97. 10.2174/092986732566618111209064810.2174/0929867325666181112090648 ↗
98. 10.1111/jcmm.1311010.1111/jcmm.13110 ↗
99. 10.1042/bse059004310.1042/bse0590043 ↗
100. 10.1038/nrm233010.1038/nrm2330 ↗